Earnings call transcript: Cavendish Hydrogen sees revenue drop in Q2 2025

Cavendish Hydrogen (CAVH) reported a sharp Q2 2025 revenue decline to €5.6 million from €9.2 million, extending a 23% twelve-month drop, yet achieved a 32% EBITDA improvement to €4.6 million due to operational efficiencies. The stock rose 1.95% post-earnings, with InvestingPro suggesting undervaluation despite weak overall financial health and rapid cash burn. Management projects a cautious near-term outlook with no new station deliveries expected for H2 2025, but remains optimistic about long-term heavy-duty hydrogen market growth and is restructuring sales to capitalize on future opportunities.

Analysis

Cavendish Hydrogen ASA (CAVH) presents a dichotomous Q2 2025 financial report, characterized by a significant revenue contraction juxtaposed with improved operational profitability. Revenue fell to €5.6 million from €9.2 million year-over-year, a direct result of fewer equipment deliveries and a depleting order backlog, which the company has not yet managed to replenish. This near-term challenge is further underscored by a cautious outlook for the remainder of 2025, with management explicitly guiding for zero new station deliveries. In stark contrast, EBITDA improved by 32% to €4.6 million, reflecting successful cost control from a prior restructuring and better margins on its service business. Operationally, the company demonstrated product viability with a 41% YoY increase in dispensed hydrogen volume globally and excellent performance from its new U.S. stations. However, the company is rapidly burning through cash, and its financial health is rated as weak despite a current cash balance of nearly €29 million. Management is addressing the sales decline by restructuring its commercial team, but success hinges on converting a challenging market, marked by delayed customer decisions, into firm orders, while leaning on long-term European regulatory tailwinds like AFIR and RED3.

Key Decisions for Investors

• Investors should exercise caution due to the severe Q2 revenue decline and the explicit guidance for zero new station deliveries in H2 2025, which signals significant near-term financial pressure.
• The most critical catalyst to monitor is new order intake; the ability of the newly restructured commercial team to rebuild the sales backlog will be the primary indicator of a potential turnaround.
• Given the rapid cash burn against a €29 million balance, investors must assess the company's financial runway and consider the stock a high-risk, long-term speculative play on the hydrogen economy, contingent on capitalizing on future regulatory support.